Journal
OBSTETRICS AND GYNECOLOGY CLINICS OF NORTH AMERICA
Volume 39, Issue 4, Pages 521-+Publisher
W B SAUNDERS CO-ELSEVIER INC
DOI: 10.1016/j.ogc.2012.09.005
Keywords
Leiomyoma; Infertility; Assisted reproductive technology (ART); Myomectomy; Hysteroscopy; Minimally invasive gynecologic surgeries; Magnetic resonance-guided focused ultrasound (MRgFUS); Uterine artery embolization (UAE)
Categories
Funding
- Intramural Research Program in Reproductive and Adult Endocrinology, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health
- National Institutes of Health
- NICHD
- PRAE
- IRTA program
Ask authors/readers for more resources
Fibroids affect 35% to 77% of reproductive-age women. When selecting a treatment plan for symptomatic fibroids, the fibroid location, size, and number must be considered. Myomectomy remains the preferred method for women with fibroid-related infertility who wish to have children or maintain fertility. Currently available medical therapies reduce symptoms in the short term but may involve side effects when used long term. Initial fertility studies are encouraging but trials are needed. Recent medical advances have led to minimally invasive approaches for women with fibroid disease, but there is a strong demand for additional treatment options.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available
Share Paper
